Pharmaceutical Translation Services

What are pharmaceutical translation services?

Pharmaceutical translation services are certified conversions of regulated pharmaceutical documents — clinical trial protocols, informed consent forms, IFUs, SmPCs, PILs and CTA dossiers — produced by ISO 17100 pharmaceutical linguists with a signed certificate of accuracy at £0.10–£0.20 per word.

Why is specialised pharmaceutical translation important?

Specialised pharmaceutical translation protects patient safety, prevents regulatory rejection and preserves informed consent validity, because generic linguists misread dosage units, drug nomenclature and QRD template constraints that trigger MHRA, EMA and FDA queries.

What types of pharmaceutical documents do we translate?

We translate 12 core pharmaceutical document families across the product lifecycle: clinical trial protocols, informed consent forms, investigator brochures, CTA and MAA dossiers, SmPCs, PILs, IFUs, PSURs, packaging and labelling, SOPs, sales and marketing collateral, and pharmacovigilance correspondence.

How much do pharmaceutical translation services cost in the UK?

Pharmaceutical translation in the UK costs £0.10–£0.20 per word, or from £25 per document for short certificates, with a 30–50% surcharge for same-day or weekend delivery — final price depends on language pair, document type and urgency, and every translation quote is free.

How long does pharmaceutical translation take?

Standard pharmaceutical translation takes 2–3 working days per document under our ISO 17100 workflow, single-page or multi-page; large regulatory dossiers, PSURs and multi-country CTA packages are scoped and quoted individually.

How do we ensure accuracy and regulatory compliance?

We ensure accuracy and compliance through an ISO 17100 workflow: subject-matter pharmaceutical linguist, independent second-linguist revision, terminology lock via translation memory, in-country review where required, and a signed certificate of accuracy on company letterhead — included at no extra cost.

Pharmaceutical translation is a specialist technical translation discipline that converts regulated drug-development, marketing-authorisation and post-approval documents into 150+ languages under an ISO 17100 workflow, priced at £0.10–£0.20 per word and shipped with a signed certificate of accuracy.

What are pharmaceutical translation services?

Pharmaceutical translation services are certified conversions of regulated pharmaceutical documents — clinical trial protocols, informed consent forms, IFUs, SmPCs, PILs and CTA dossiers — produced by ISO 17100 pharmaceutical linguists with a signed certificate of accuracy at £0.10–£0.20 per word.

The service sits inside a broader medical and pharmaceutical language services stack, but stays narrower than general medical translation. Every translation ships from our London office to global pharmaceutical clients.

How does pharmaceutical translation differ from medical translation?

Medical translation covers the full clinical and healthcare estate; pharmaceutical translation is the narrower regulated sub-domain focused on drug development, marketing authorisation and post-approval safety documents, where regulator templates and second-linguist QC define acceptance. Route broader clinical requests to our Medical Translation pillar.

Who is this specialist medical and pharmaceutical service for?

Global pharmaceutical companies, biotech firms, CROs, MHRA submitters and academic clinical research groups use this service for regulator-facing and patient-facing content in 150+ languages. Typical pharmaceutical clients run 20+ language versions of the same dossier.

Why is specialised pharmaceutical translation important?

Specialised pharmaceutical translation protects patient safety, prevents regulatory rejection and preserves informed consent validity, because generic linguists misread dosage units, drug nomenclature and QRD template constraints that trigger MHRA, EMA and FDA queries. Every document in a pharmaceutical programme — from a single PIL to a full MAA dossier — carries direct patient-safety implications, which is why specialist knowledge is non-negotiable at every stage of the translation workflow.

How does accurate translation protect patient safety and patient outcomes?

Accurate translation of dosage, contraindications and administration routes on IFUs and PILs prevents mis-dosing incidents; second-linguist QC under ISO 17100 catches numeric and unit errors before release. Consistent patient outcomes depend on unit fidelity across every translated content variant. Patient Information Leaflets, for example, require very specialised knowledge and expertise, because regulatory bodies maintain strict guidelines on how they must be structured and what information they must contain — leaving no room for approximation or generic phrasing. A qualified pharmaceutical linguist understands these structural constraints and applies them consistently across every language version.

What happens when pharmaceutical documents are translated poorly?

Poor pharmaceutical translation causes regulator RFIs, IRB rejection of consent forms, product recalls and delayed time to market — costs that dwarf the £0.10–£0.20 per word price of qualified pharmaceutical linguists. Linguistic review can also surface issues in the source text itself; translator notes are frequently valuable to the qualified person at the pharmaceutical company, flagging ambiguities that apply to one international market but not another. Four failure modes recur consistently:

1. Dosage unit conversion errors on IFUs.
2. Non-QRD section headings on SmPCs.
3. Semantic drift between forward and back translation of ICFs.
4. Promotional claims that breach local codes on sales and marketing content.

What types of pharmaceutical documents do we translate?

We translate 12 core pharmaceutical document families across the product lifecycle: clinical trial protocols, informed consent forms, investigator brochures, CTA and MAA dossiers, SmPCs, PILs, IFUs, PSURs, packaging and labelling, SOPs, sales and marketing collateral, and pharmacovigilance correspondence.

Document type	Typical word band	Turnaround under ISO 17100
IFU (single device)	500–2,500	2–3 working days
SmPC	3,000–8,000	2–3 working days
PIL / patient information leaflets	800–2,000	2–3 working days
ICF (informed consent)	2,000–6,000	2–3 working days
CTA dossier	25,000+	Scoped programme
MAA module	50,000+	Scoped programme
PSUR / PBRER	15,000–40,000	Scoped programme
Packaging artwork	50–500	2–3 working days

Which clinical trial translations do we deliver?

Clinical trial translations include study protocols, informed consent forms, patient-reported outcome instruments (eCOA/PRO), investigator brochures, case report forms, patient diaries and IRB correspondence. Each clinical trial deliverable is mapped to ICH E6(R3) formatting at revision stage.

How do we translate SmPCs, PILs and patient information leaflets?

SmPCs, PILs and patient information leaflets are translated against the EMA QRD template so section headings, pictograms and readability rules pass linguistic review at submission. In-country pharmaceutical linguists handle Member State language variants.

Do we translate medical devices and combination product IFUs?

Medical devices and drug-device combination IFUs are translated under MDR and IVDR language obligations, with terminology aligned to the drug-side SmPC to keep dosage and administration language consistent.

What sales and marketing pharmaceutical content do we localise?

Sales and marketing content — MSL decks, HCP training, congress materials and DTC websites — is localised rather than literally translated, with claims screened against local promotional codes. Localisation covers tone, references and unit conventions.

How much do pharmaceutical translation services cost in the UK?

Pharmaceutical translation in the UK costs £0.10–£0.20 per word, or from £25 per document for short certificates, with a 30–50% surcharge for same-day or weekend delivery. Final price depends on language pair, document type and urgency, and every translation quote is free.

Price driver	Effect on rate
Language pair rarity	Moves rate toward £0.20 per word
Subject-matter complexity (SmPC vs SOP)	Regulator-facing content sits at the upper band
Document length beyond 250 words	Per-word pricing replaces per-document pricing
Urgency (same-day / weekend)	30–50% surcharge

Pharmaceutical work sits inside our wider Technical Translation pillar and is priced identically at £0.10–£0.20 per word, because subject-matter expertise is applied consistently across every SME domain.

What drives pharmaceutical translation pricing?

Four factors drive pharmaceutical translation pricing: language pair rarity, subject-matter complexity, document length beyond 250 words, and urgency — with same-day or weekend delivery adding a 30–50% surcharge.

How much should I pay for translation services in the UK?

Expect £0.10–£0.20 per word for certified pharmaceutical and technical translation, or from £25 per standard document for short certificates. Prices below that band usually indicate unqualified translators whose work regulators reject.

How much does the NHS pay for translation services?

NHS translation rates are set by regional framework contracts and are not published as a single figure. Commercial pharmaceutical translation prices at £0.10–£0.20 per word reflect ISO 17100 QC and specialist linguists, which framework rates often exclude.

How much do professional translation services typically cost?

Professional translation services in the UK typically cost £0.10–£0.20 per word for certified specialist work, or from around £0.08 per word for standard non-certified translation. Certification, subject specialism and urgency lift the rate within that band.

How do I get a free pharmaceutical translation quote?

Send the source text, target languages and deadline to Certified Translation Services UK on +44 20 4569 1419; a free translation quote is returned within one working hour, Monday to Saturday, 9:00–18:00.

Get a quote

How long does pharmaceutical translation take?

Standard pharmaceutical translation takes 2–3 working days per document under our ISO 17100 workflow, whether single-page or multi-page. Large regulatory dossiers, PSURs and multi-country CTA packages are scoped and quoted individually, with programme timelines agreed at quotation so that submission deadlines are never compromised. Every turnaround commitment is built around the mandatory second-linguist QC pass, ensuring speed never comes at the expense of accuracy.

Which documents fit the standard 2–3 working day turnaround?

Single IFUs, PILs, short clinical trial protocols, ICFs and packaging leaflets under typical word counts fit the 2–3 working day standard. These document types have a defined structure and predictable word count, which allows our pharmaceutical linguists to plan the translation, revision and QC stages within the standard window. Longer CTA dossiers, MAA modules and PSURs run on a scoped programme timeline, agreed at quotation, and are broken into manageable workstreams to maintain consistency across all modules. For multi-language projects covering several of our 150+ available languages simultaneously, parallel linguist teams are assigned to preserve a unified delivery date.

Do you offer same-day and weekend delivery on pharmaceutical translation?

Same-day and weekend delivery are available at a 30–50% surcharge, subject to linguist availability for the target language pair and pharmaceutical subject area. Accuracy and speed remain linked: even on urgent jobs, the second-linguist QC pass is mandatory, and a signed certificate of accuracy is included with every delivery. Requesting urgent turnaround at the point of quote allows us to confirm linguist availability and provide a firm commitment on delivery time before work begins.

How do we ensure accuracy and regulatory compliance in pharmaceutical translation?

We ensure accuracy and compliance through an ISO 17100 workflow: subject-matter pharmaceutical linguist, independent second-linguist revision, terminology lock via translation memory, in-country review where required, and a signed certificate of accuracy on company letterhead — included at no extra cost.

1. Source text intake, scoping and NDA countersignature.
2. Forward translation by a qualified pharmaceutical linguist with life science background.
3. Independent revision by a second linguist against the source and regulator template.
4. Terminology lock in the translation memory and glossary.
5. Back-translation and reconciliation for informed consent forms, where required.
6. Regulator-template validation (EMA QRD, MHRA, FDA, ICH E6(R3)).
7. Signed certificate of accuracy issued on company letterhead.

Regulator / standard	Template or expectation	Validated at QC stage
EMA	QRD template for SmPC, PIL, labelling	Yes
MHRA	Post-Brexit UK-specific labelling and PIL rules	Yes
FDA	IND/NDA structural expectations	Yes
ICH	E6(R3) Good Clinical Practice for protocols and ICFs	Yes
Swissmedic / PMDA	Local language and format conventions	Yes

What does the ISO 17100 workflow cover for pharmaceutical content?

ISO 17100 mandates translator qualifications, revision by a second linguist, project management and traceability. For pharmaceutical content we add regulator-template validation at revision stage.

How do qualified translators handle medical terminology consistency across languages?

Qualified translators lock medical terminology in a project glossary and translation memory, so drug names, dosage units and route-of-administration verbs stay consistent across SmPCs, PILs and IFUs. A single lead reviewer owns each programme.

Do you provide certified translation with a signed certificate of accuracy?

Every pharmaceutical translation ships with a signed certificate of accuracy on company letterhead, accepted by the MHRA, ethics committees and the Home Office. Notarisation or apostille is available on request via our Certified Translation service.

How do you ensure complete confidentiality of pharmaceutical documents?

Confidentiality is protected by a signed non-disclosure agreement with every linguist, ISO/IEC 27001-aligned handling and secure encrypted transfer — matching Sponsor and CRO audit expectations. Access is limited to the named project team.

Do pharmaceutical translation services include regulatory submissions?

Yes — pharmaceutical translation covers regulatory submissions including CTA dossiers, MAA modules under EMA QRD, MHRA post-Brexit filings, FDA IND/NDA sections and PSUR/PBRER updates, with translations formatted to each regulator's template at revision stage. Regulatory submission translation is one of the most technically demanding document families we handle, requiring linguists who are not only fluent in the target language but also thoroughly familiar with the formatting conventions, controlled vocabulary and structural requirements each authority mandates.

Which regulatory bodies do we translate regulatory content for?

We translate content for the MHRA, EMA, FDA, Swissmedic, PMDA and national competent authorities across the EU. The target-country regulator determines the applicable template and required language pair. Regulatory requirements are validated at QC to ensure that section headings, controlled terminology and formatting conventions align precisely with the relevant authority's current guidance. Our coverage spans more than 150 languages, meaning a single multi-country submission can be handled entirely within one coordinated programme, with a consistent termbase applied across every target language.

How do we handle informed consent form translation?

Informed consent form translation is a regulated process that directly affects participant safety and trial integrity. Our standard workflow follows a forward translation → second-linguist revision → optional back-translation and reconciliation path, so IRB and REC panels can verify semantic equivalence before subject enrolment begins. Where a back-translation is required by the sponsor or ethics committee, we assign a separate, independent linguist to the back-translation step, ensuring the reconciliation process is genuinely independent and audit-ready. A signed certificate of accuracy accompanies every completed ICF, and notarisation or apostille is available on request.

What are the key challenges in pharmaceutical translation?

The key challenges in pharmaceutical translation are five: dense medical terminology, regulator-specific templates, numeric and unit fidelity in dosage, tight submission deadlines, and multi-country consistency across 20+ language versions of the same dossier. Each challenge compounds the others — a terminology inconsistency in one language version can propagate across an entire programme if there is no locked termbase and no single lead reviewer tracking equivalence throughout.

How do you keep pharmaceutical terminology consistent across languages?

Consistency across languages comes from a locked termbase, translation memory reuse and a single lead reviewer per programme, so the same active substance name, adverse-event descriptor and dosage expression maps identically in every target language. Linguistic research during the translation phase can also surface issues in the source text — for instance, a disposal instruction that applies in one regulatory market but not another — and translator notes flag these discrepancies for the qualified person at the pharmaceutical company before they reach the regulator. This kind of source-text scrutiny is a feature of specialist pharmaceutical translation that generic language services do not provide.

How do you handle Japanese translation and other complex language pairs?

Japanese translation and other complex pairs — including Simplified Chinese, Arabic and Korean — use in-country pharmaceutical linguists with PMDA or NMPA submission experience, because script direction, honorifics and regulator-specific conventions demand native-speaker review by someone with direct submission familiarity. These language pairs are included within our 150+ language coverage, and each assignment is matched to a linguist whose subject-matter background aligns with the specific document type, whether that is a PMDA-format SmPC, a NMPA clinical study report or an Arabic-language PIL structured to Gulf authority requirements.

How do AI and human expertise combine in pharmaceutical translation?

AI translation accelerates first-draft output on low-risk content, but professional human pharmaceutical linguists own every regulator-facing and patient-facing document — ICFs, SmPCs, PILs, IFUs and submissions — because MHRA, EMA and FDA acceptance requires signed human accountability.

Content type	AI translation acceptable?	Why
Internal SOPs	Yes, with human post-editing	Non-regulated, internal use
Sales training decks	Yes, with human post-editing	Not shown to patients or regulators
Discovery-phase literature scanning	Yes	Signal-finding, not submission
Informed consent forms	No	IRB acceptance requires signed linguist
SmPCs, PILs, IFUs	No	Regulator template compliance
CTA / MAA / PSUR	No	Named human accountability

When is AI translation acceptable for pharmaceutical content?

AI translation is acceptable for internal-only content — SOP drafts, sales training, discovery literature scanning — where human post-editing under ISO 18587 is applied before release. AI pharmaceutical translation never touches submission content.

When is professional human translation mandatory?

Professional human translation is mandatory for informed consent forms, SmPCs, PILs, IFUs, CTA and MAA dossiers, PSURs and any content submitted to a regulator or shown to a patient — because a signed certificate of accuracy requires a named qualified linguist.

What should you look for in a reliable pharmaceutical translation company?

A reliable pharmaceutical translation company demonstrates six core traits: ISO 17100 and ISO/IEC 27001-aligned certification, qualified pharmaceutical linguists with life-science backgrounds, a proven track record across global pharmaceutical and biotech programmes, transparent per-word pricing, mandatory second-linguist QC on every job, and a signed certificate of accuracy included as standard — not as a paid add-on.

• ISO 17100 process certification and ISO/IEC 27001-aligned data handling, so every job is traceable and audit-ready.
• Pharmaceutical linguists with life science, pharmacy or clinical research qualifications, matched to each document type.
• Deep subject-matter portfolio spanning clinical trial protocols, regulatory dossiers, patient-facing materials and commercial content.
• Transparent £0.10–£0.20 per word pricing with a minimum from £25 per document for short certificates — published clearly, not hidden behind a form.
• Second-linguist QC on every job, evidenced at sponsor or regulator audit without the need for special preparation.
• Signed certificate of accuracy on company letterhead as standard, with notarisation and apostille available on request.
• Signed NDA per linguist and secure encrypted file transfer, so confidential compound data and trial results are protected throughout.

What credentials should pharmaceutical linguists hold?

Pharmaceutical linguists should hold a linguistics qualification plus a life science, pharmacy or clinical research background, and demonstrate deep subject-matter experience on the specific document family being translated. PILs, for example, require a linguist who understands both the regulatory structure that authorities mandate and the plain-language principles that make patient-facing content genuinely comprehensible — two distinct competencies that a general medical translator may not combine. A second-linguist reviser with equivalent qualifications then independently reviews the translation before delivery.

Why work with an ISO-certified translation agency?

An ISO-certified translation agency documents its entire process, mandates second-linguist QC and evidences full traceability during sponsor or regulator audit — advantages that freelance markets and non-specialist agencies cannot reliably replicate. ISO 17100 certification means the workflow is verified externally, not self-declared, and ISO/IEC 27001-aligned data handling means your compound data, trial results and patient information are governed by documented security controls, including signed NDAs for every linguist on the project.

What is the highest paid job in translation?

The highest paid translation work is specialist regulatory and pharmaceutical translation — including patent, clinical trial and MAA-dossier translation — because subject-matter expertise, regulator-template fluency and confidentiality risk command rates at the top of the £0.10–£0.20 per word band, with rare language pairs earning more. Pharmaceutical translation is demanding in ways that general commercial translation is not: a linguist must simultaneously master the target language, the scientific domain and the regulatory formatting conventions of the receiving authority, making genuine expertise scarce and therefore well compensated.

What is the highest paid translating job across the medical industry?

Within the medical industry, the highest paid translating job is regulator-facing pharmaceutical submission work — MAA modules, PSURs and CTA dossiers — where named linguist accountability, template mastery and the direct patient-safety consequences of every word justify top-of-band rates. Linguists who combine native-language fluency with a clinical research or pharmacy qualification, and who have accumulated experience across multiple regulatory jurisdictions such as EMA, MHRA, FDA and PMDA, are among the most sought-after professionals in the language industry. For buyers, this scarcity reinforces the importance of working with an agency that has established, vetted relationships with these specialists rather than sourcing ad hoc from open freelance markets.

How do you request a pharmaceutical translation quote?

Requesting a pharmaceutical translation quote is straightforward: call +44 20 4569 1419 or email your source files and target languages to Certified Translation Services UK, Suite 544, Unit B, 63-66 Hatton Garden, London EC1N 8LE. Quotes return within one working hour, Monday to Saturday, 9:00–18:00, and are fixed on the £0.10–£0.20 per word band — with short certificates priced from £25 per document. Providing your source text, target languages and required delivery date at the point of enquiry allows us to confirm linguist availability, apply any applicable urgent-delivery assessment and return a firm, itemised quote without follow-up calls.

1. Send source files, target languages and deadline by phone or email — scanned PDFs, Word documents and InDesign files are all accepted.
2. Receive a fixed quote within one working hour on the £0.10–£0.20 per word band, with urgent surcharges (30–50%) flagged transparently if your deadline requires same-day or weekend delivery.
3. Countersign the NDA and approve the schedule — every project is covered by a signed confidentiality agreement before any files are shared with the assigned pharmaceutical linguists.
4. Receive the certified translation in 2–3 working days, complete with a signed certificate of accuracy on company letterhead; notarisation and apostille can be arranged at the same time if required for your submission.

Our buyer base spans global pharmaceutical companies, biotech firms, CROs and academic clinical research groups, so our quotation process is designed to accommodate both single urgent documents and large multi-language regulatory programmes with equal efficiency.

Frequently asked questions

How much should I pay for translation services?

For certified translation in the UK, you should expect to pay £0.10–£0.20 per word, depending on the language pair and subject matter. Single personal documents — such as birth certificates, marriage certificates, diplomas or passports — start from £25 per document. More technical or regulatory content, such as pharmaceutical dossiers, clinical trial documents or regulatory submissions, sits at the higher end of the rate range and may be quoted individually for large projects. Standard turnaround is 2–3 working days; same-day or weekend delivery carries a 30–50% surcharge.

How much do professional translation services typically cost?

Professional certified translation services in the UK typically cost £0.10–£0.20 per word, with short personal certificates quoted from £25 per document. Highly specialised fields — including pharmaceutical, medical and legal translation — tend to attract rates at the upper end of that range, reflecting the subject-matter expertise and dual-linguist review required. Large regulatory or technical projects, such as pharmaceutical dossiers or clinical study reports, are quoted individually based on volume, complexity and deadline. A signed certificate of accuracy is included at no extra cost.

How much do translation services cost in the UK?

In the UK, certified translation is typically priced at £0.10–£0.20 per word, depending on the language pair and subject. Single personal documents (birth, marriage or death certificates, diplomas, passports, IDs) start from £25 per document. Standard turnaround is 2–3 working days; urgent same-day or weekend delivery is available at a 30–50% surcharge. Specialist pharmaceutical, regulatory and clinical translation projects are scoped and quoted individually. Every certified translation includes a signed certificate of accuracy and is completed to an ISO 17100 process with a second-linguist review.

Can ChatGPT do translation?

ChatGPT can produce rough translations, but it cannot provide the certified, legally valid translations required for pharmaceutical regulatory submissions, clinical trial documents or official UK authorities. Certified translation demands a qualified human translator with subject-matter expertise, a second-linguist review, and a signed certificate of accuracy — none of which AI tools supply. For pharmaceutical content in particular, mistranslations in dosage instructions, clinical data or labelling can carry serious regulatory and safety consequences. Certified Translation Services UK works to an ISO 17100 process to meet these exacting standards.